GLP Watchdog

Fridays vs Zealthy

Zealthy has an open FDA warning letter dated September 9, 2025. Fridays has none. No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Zealthy

Fridays logo

Fridays

5.8/10

Zealthy logo

Zealthy

5.6/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
$286/moCompounded semaglutide injection, medication only, membership extra
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Fridays
Visit Zealthy

Neither Fridays nor Zealthy pays us. Links to them earn nothing. Scores: Fridays 5.8, Zealthy 5.6. How we are paid

What the record shows

  1. 01

    Zealthy has an open FDA warning letter dated September 9, 2025. Fridays has none.

  2. 02

    Fridays names four pharmacies. Zealthy names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top.

  4. 04

    Only Fridays lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    Zealthy lists all 50 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Zealthy

Compounded semaglutide injection

$249/mo

$2,988 a year

$286/mo

medication only, membership extra; not compared

Compounded tirzepatide injection

$359/mo

$4,308 a year

$351/mo

medication only, membership extra; not compared

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Price includes
Medication, clinician visits, coaching
Clinician visits, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Monthly membership that renews automatically; quarterly, semi-annual and annual memberships are also sold
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Medication, consultation and membership charges are non-refundable

Read off each seller’s own pages. Fridays: October 30, 2026. Zealthy: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • No FDA warning letter on record
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Zealthy does not price
  • Names its compounding pharmacy
  • Publishes no state list
Visit Fridays

The case for Zealthy

5.6/10

The record gives Zealthy no edge on this pair.

  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy
  • Lowest price covers the medication only, with a separate membership on top
Visit Zealthy

Scores

Fridays 5.8 · Zealthy 5.6 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
3.0

Trust & Safety15%

5.5A
vs
B
2.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
5.5

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Zealthy: questions

Zealthy has an open FDA warning letter dated September 9, 2025. Fridays has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Zealthy names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Zealthy states you can cancel at any time; refunds: medication, consultation and membership charges are non-refundable.
Neither Fridays nor Zealthy pays us. Links to them earn nothing. Scores: Fridays 5.8, Zealthy 5.6.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks